01 — At a Glance
The Agrochemical Company That Lost Momentum in Q3
- 52-Week High / Low₹665 / ₹367
- FY25 Revenue (Full Year)₹3,149 Cr
- FY25 PAT (Full Year)₹506 Cr
- Full-Year EPS (FY25)₹10.13
- Annualised EPS (Q3×4)₹6.00
- Book Value₹64.0
- Price to Book6.15x
- Dividend Yield0.30%
- Debt / Equity0.02x
- CRISIL RatingAA/Stable
Auditor’s Opening Note: Sumitomo Chemical India cruised through FY25 with ₹3,149 crore revenue and record ₹506 crore PAT. But Q3 FY26 hit a speedbump—revenue dropped 12% YoY to ₹568 crore, weighed down by delayed rabi sowing, continued Chinese supply glut, and a ₹16 crore one-time labour code charge. Stock bounced from ₹367 to ₹665 in 52 weeks. Currently at ₹394. P/E is 36.2x—nearly 50% above the sector median of 24.99x. The narrative shifted from growth to execution.
02 — Introduction
The Japanese Agrochemical Giant Playing the Long Game in India
Let’s talk about Sumitomo Chemical India. Not a household name like Monsanto or Syngenta. Not even a name that makes farmers whisper with reverence like Castrol does for mechanics. But this is Japan’s Sumitomo Chemical Company’s India play—200+ brands, 700+ SKUs, 15,000+ distributors, and one of the most diversified agrochemical portfolios in the country.
The company has grown 14x over the past 15 years (FY11 to FY25). From ₹2.3 billion to ₹31.5 billion in revenue. ROCE holding steady at 25%. A debt-free balance sheet. And management is now betting ₹65 crores on capacity expansion across Bhavnagar, Tarapur, and Dahej—ambitious moves for a company that just got whacked by a weak quarter.
Q3 FY26 was rough. Monsoon withdrawal delays. Rural liquidity tightness. Farmer preference for fertilisers over pesticides. Chinese dumping. And then—boom—a surprise ₹16 crore exceptional charge for labour code impact. Core operations remained stable, but the stock market saw red. Management is unfazed. “Our business is seasonal. Monitor us annually,” they said in the concall. Fair point. But let’s dig into what happened, why it happened, and whether the capex bets make sense.
Concall Insight (Jan 2026): Management emphasized that Q3 is structurally weaker for the agro-chem sector due to seasonality. They’re guiding for 8–12% medium-term revenue growth, backed by recovery in exports and new product launches. Translation: trust the process, not the quarter.
03 — Business Model: Agrochemicals 101 With A Japanese Twist
They Spray Poison. Strategically. Across 50+ Countries.
Sumitomo Chemical India operates in a simple business: India’s farmers need pesticides. Lots of them. The company procures active ingredients (technical grade actives) from its parent Sumitomo Chemical Company Limited in Japan, buys some from third parties, and formulates them into products sold under 200+ brands. Insecticides dominate at 39% of FY25 revenue. Herbicides are 24%. Fungicides, plant growth regulators, metal phosphides, and animal nutrition fill out the portfolio.
The magic is in the distribution network: 26 states, 60 depots, 15,000+ direct distributors, and ~40,000 dealers. No product contributes more than 15% of revenue. No crop is over-concentrated. And the parent company? It’s Sumitomo Chemical Co., Japan—a ₹40,000+ crore global chemical conglomerate with presence in 160+ countries. Access to proprietary chemistry, global R&D, and supply chain gives SCIL a competitive moat. The company is essentially licensed to sell world-class agrochemical innovation in India at scale.
Revenue split: 81% domestic, 19% exports. Domestic is 82% branded, 18% bulk. FY25 saw strong exports recovery—up 66% YoY from a depressed FY24 base. But Q3 has been weak. Why? Monsoon volatility, Chinese imports undercutting prices, and seasonal lows. Management continues to maintain a balanced pipeline of generic (71% of revenue) and specialty products (29%), which de-risks concentration risk.
Insecticides39%Largest Segment
Herbicides24%2nd Largest
PGR & Others18%High-Margin
Exports Mix19%Of Revenue
The Hidden Strength: 75% of revenue hits in H1 (April to September). Q3 and Q4 are structurally weak because kharif season ends and rabi hasn’t picked up. This is not a bug—it’s structural to Indian agriculture. Management knows. Investors should too.
💬 Do you grow crops? If yes, have you ever heard of or used any Sumitomo Chemical brand? Drop the name in comments!
04 — Financials Overview: Q3 FY26 — The Numbers
When Good Companies Have Bad Quarters
Result type: Quarterly Results | Q3 FY26 EPS: ₹1.50 | Annualised EPS (Q3×4): ₹6.00 | Full-year FY25 EPS: ₹10.13
| Metric (₹ Cr) |
Q3 FY26
Dec 2025 |
Q3 FY25
Dec 2024 |
Q2 FY26
Sep 2025 |
YoY % |
QoQ % |
| Revenue | 568.0 | 641.9 | 929.8 | -11.5% | -39.0% |
| EBITDA | 99.5 | 106.1 | 218.0 | -6.2% | -54.3% |
| EBITDA Margin % | 17.5% | 16.5% | 23.4% | +98 bps | -593 bps |
| PAT (excl. exceptional) | 91.9 | 87.4 | 177.8 | +5.2% | -48.3% |
| EPS (₹) | 1.50 | 1.69 | 3.56 | -11.2% | -57.9% |
Gross Margin Expansion in Pain: Despite revenue falling 12% YoY, gross margin expanded 522 basis points to 47.4% (from 42.1% in Q3 FY25). Why? Discontinuation of low-margin animal nutrition (AND) business (₹72 crore revenue hit), favourable product mix, and disciplined pricing. EBITDA margin improved to 17.5% from 16.5% YoY. The ₹16 crore labour code charge was the reason PAT fell 13% YoY to ₹75.8 crore. Excluding that, PAT growth was actually positive. Core operations were resilient even in a weak demand environment.
05 — Valuation: Fair Value Range
Is ₹394 a Deal or a Dud?
Join 10,000+ investors who read this every week.
